value - Trading at 3.0x P/S and 2.5x P/B with 4.3% FCF yield suggests value orientation…
Low direct sensitivity given minimal debt (0.01 D/E ratio) means negligible financing cost exposure.
Watch on earnings: USD/INR exchange rate (DEXCHUS equivalent for India) affecting API import costs and export revenue realization, Indian pharmaceutical market growth rates (IMS Health data) for volume trends, Crude oil prices (CLUSD) as proxy for petrochemical-derived API and packaging material costs.
One Sentence Summary:
FDC: the story is balanced — domestic pharmaceutical market growth rates in india (volume-driven prescription trends).
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.